is part of the Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

BASF to invest €200 million in plastic additives business

BASF to invest €200 million in plastic additives business

The planned investment focuses on capacity expansions at sites in North America and Europe as well as investments in automation, digital technologies and modelling.

Over the course of the next five years, BASF (Ludwigshafen, Germany) plans to invest globally more than €200 million in its plastic additives business, approximately half of which in Asia, focusing on capacity expansions and operational excellence.

“BASF will strengthen its plastic additives business with investments in additional capacities to meet increasing global demand for antioxidants, as well as light stabilizers. Moreover, we will invest in digital processes and technology to support our customers as a reliable supplier in all regions,” said Dr. Christian Fischer, President, BASF Performance Chemicals division.

The planned set of measures focuses on capacity expansions at sites in North America and Europe, as well as investments in automation, digital technologies and modelling. In addition, BASF plans to strengthen its plastic additives production footprint in Asia.

In addition to investments, innovation remains an integral part of BASF’s business strategy. At the K Fair in Düsseldorf, Germany, BASF’s plastic additives business recently launched two new light stabilizers:

Tinuvin 880, based on a new chemistry, is a medium molecular weight light stabilizer which provides significantly improved light stability, especially in interior car applications with the additional benefit of offering higher thermal stability.

Tinuvin XT 55 provides formulators with very good durability and excellent secondary properties such as color stability, gas fading and extraction resistance. Using this new solution, an excellent cost performance will be achieved by adjusting dosage and other formulation components to end application conditions and expectations.

Both products are undergoing sampling at key customers.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish